Altretamine for ovarian cancer1999

Altretamine for ovarian cancerPharmacoEconomics & Outcomes News · 1999

AltretamineReactions Weekly · 1987

Clinical Pharmacokinetics of AltretamineGiovanna Damia,Dr Maurizio D’lncalci · Clinical Pharmacokinetics · 1995

Altretamine improves treatment outcome in ovarian cancerInpharma Weekly · 1990

AltretamineReactions Weekly · 2016

Hexamethylmelamine (altretamine): Early National Cancer Institute trialsYoung, Robert C. · Cancer Treatment Reviews · 1991

Inhibitors of the anaplastic lymphoma kinaseMologni, Luca · Expert Opinion on Investigational Drugs · 2012

Drugs for insomniaZisapel, Nava · Expert Opinion on Emerging Drugs · 2012

ARB and CardioprotectionAkazawa, Hiroshi; Yabumoto, Chizuru; Yano, Masamichi; Kudo-Sakamoto, Yoko; Komuro, Issei · Cardiovascular Drugs and Therapy · 2013

Melatonin in cardiovascular diseaseDominguez-Rodriguez, Alberto · Expert Opinion on Investigational Drugs · 2012

Drugs for bone healingBrandi, Maria Luisa · Expert Opinion on Investigational Drugs · 2012

Rheumatoid arthritis: developing pharmacological therapiesMoreland, Larry W; Misischia, Richard J · Expert Opinion on Investigational Drugs · 2002

Emerging drugs for asthmaQuirce, Santiago; Bobolea, Irina; Barranco, Pilar · Expert Opinion on Emerging Drugs · 2012

MDMA: A Review of Epidemiological DataLandry, Mim J. · Journal of Psychoactive Drugs · 2002